The Senate
has raised alarm on the alleged circulation of 42 anti-malaria drugs that have
been banned in Europe but are being administered and sold to Nigerians in some
hospitals and pharmacies. During plenary yesterday, the senate ordered its
committee on Health (Secondary and Tertiary), led by Senator Olarewaju Tejuoso,
to urgently carry out an indepth investigation into the allegation and report
back for further action. The Senate resolution came after a motion by Senator
Theodore Orji, was read on the floor of the house.
Orji in his
motion said “The Senate notes that recently the European Union banned the sale
and consumption of 42 Anti-Malaria Drugs in all countries within the European
Union. It notes that the 42 Anti-Malaria Drugs are:
Alaxin 60mg
tablet (dihydroartémisinine)B/8;
Alaxin oral
suspension (dihydroartémisinine) FL/80ml;
Amodiaquine
200mg compressed B/1000;
Amodiaquine
200mg compressed B/1000;
Arinate
100mg tablet (artésunate) B/6;
Arinate 50mg
tablet (artésunate) B/6;
Arsumax 50mg
tablet (artésunate) B/12;
Artemax 60mg
tablet (dihydroartémisinine) B/8;
Artémédine
40mg capsule (artemether) B/12;
Artémédine
50mg tablet (artemether) B/12;
Artenam 50mg tablet (artemether) B/14
Artenam 60mg
tablet (artemether) B/8;
Artésiane
300mg child powder oral suspension (artemether) FL/38g;
Artésunate
100mg compressed B/120;
Artésunate
50mg tablet B/120;
Artexin 60mg
tablet (dihydroartémisinine) B/8;
Camoquin
200mg tablet (amodiaquine) B/9;
Camoquin
200mg tablet (amodiaquine) B/25 blisters;
Camoquin
200mg tablet (amodiaquine) B/55 blisters;
Camoquin
200mg tablet (amodiquine) B/24;
Camoquin 600
mg tablet (amodiaquine) B/3;
Camoquin
oral suspension 50mg/ 5ml (amodiaquine) FL/60ml;
Cotecxin
oral suspension (dihydroartémisinine) FL/80ml;
Cotecxin
60mg tablet (dihydroartémisinine) B/8;
Daraprim
tablet (pyriméthamine) B/30;
and Falcinil
50mg tablet (artésunate) B/12.
0 Comments